UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000027566
Receipt No. R000031606
Scientific Title Clinical study of sinus floor augmentation by hydroxyapatite/collagen composite material
Date of disclosure of the study information 2017/05/31
Last modified on 2021/11/18 (Ver. 11)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Clinical study of sinus floor augmentation by hydroxyapatite/collagen composite material
Acronym Sinus floor augmentation by HAp/Col
Scientific Title Clinical study of sinus floor augmentation by hydroxyapatite/collagen composite material
Scientific Title:Acronym Sinus floor augmentation by HAp/Col
Region
Japan

Condition
Condition missing tooth
Classification by specialty
Dental medicine
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To assess bone negeneration for sinus flooraugmentation.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes ISQ 6 months after implantation.
Key secondary outcomes 1. new bone formation.

Base
Study type Others,meta-analysis etc

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit
90 years-old >=
Gender Male and Female
Key inclusion criteria Patient who needs sinus floor augmentation for dental implantation.
Key exclusion criteria 1. uncontrolled DM
2. severe renal and hepatic disorders.
Target sample size 10

Research contact person
Name of lead principal investigator
1st name Seigo
Middle name
Last name Ohba
Organization Nagasaki University
Division name Division of Regenerative Oral Surgery
Zip code 852-8588
Address 1-7-1 Sakamoto, Nagasaki
TEL 095-819-7704
Email sohba@nagasaki-u.ac.jp

Public contact
Name of contact person
1st name Seigo
Middle name
Last name Ohba
Organization Nagasaki University
Division name Division of Regenerative Oral Surgery
Zip code 852-8588
Address 1-7-1 Sakamoto, Nagasaki
TEL 095-819-7704
Homepage URL
Email sohba@nagasaki-u.ac.jp

Sponsor
Institute Nagasaki University
Institute
Department

Funding Source
Organization Nagasaki University
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Nagasaki University
Address 1-7-1 Sakamoto, Nagasaki
Tel 095-819-7704
Email sohba@nagasaki-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 05 Month 31 Day

Related information
URL releasing protocol https://www.jstage.jst.go.jp/article/josnusd/63/3/63_21-0163/_article/-char/ja/
Publication of results Unpublished

Result
URL related to results and publications https://www.jstage.jst.go.jp/article/josnusd/63/3/63_21-0163/_article/-char/ja/
Number of participants that the trial has enrolled 11
Results This material induces the new bone formation in the maxillary sinus. On the other hand, some implants could not acquire the osseointegration when the original bone volume was insufficient.
Results date posted
2021 Year 11 Month 18 Day
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics Nineteen implants were placed into 14 maxillary sinuses.
Participant flow Two implants were placed in 2 maxillary sinuses via the crestal approach, and 17 implants (OsseoSpeed; 10 implants, Finesia; 1 implant, Straumann; 6 implants) were placed in 12 maxillary sinuses via the lateral approach.
Adverse events Three implants were lost.
Outcome measures The alveolar bone height and cortical bone thickness of the alveo- lar bone ridge (cortical bone thickness) at the implant placement positions were measured on preoperative CBCT (3D Accuitomo F17D, Morita, Kyoto, Japan) images. Insertion torque and ISQ were also measured.
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2015 Year 11 Month 05 Day
Date of IRB
2015 Year 11 Month 05 Day
Anticipated trial start date
2015 Year 11 Month 05 Day
Last follow-up date
2019 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information presentation at the annual meeting of Japanese association of oral implanvology in 23018.


Stop the exam.

Management information
Registered date
2017 Year 05 Month 31 Day
Last modified on
2021 Year 11 Month 18 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031606